Home / Ingredient Directory / Citicoline

Reviewed by Yannis Lopez · Nutrition Industry Veteran

Last updated: July 10, 2026

Cognitive Health Nootropic

Citicoline

CDP-Choline — dual-action brain support raising both acetylcholine and uridine

Raises acetylcholine & uridine

Strong evidence in older adults

Important: These statements have not been evaluated by the FDA. This information is not intended to diagnose, treat, cure, or prevent any disease. Always consult your physician before starting any supplement.

Overview

Citicoline (also known as CDP-choline, or cytidine diphosphate-choline) is a naturally occurring compound found in every cell of the body. When you take it as a supplement, it's broken down into two components: choline and cytidine. The choline is used to synthesize acetylcholine — the neurotransmitter central to memory, attention, and learning. The cytidine converts to uridine, a building block for brain cell membranes and a modulator of dopamine signaling.

This dual mechanism sets citicoline apart from simple choline supplements. It's not just topping up one neurotransmitter — it's providing raw material for both neurotransmitter production and the structural integrity of neurons. Clinical research, particularly in older adults and those recovering from stroke or cognitive decline, has consistently shown benefits for attention, memory, and processing speed.

Potential Benefits

Focus & Attention

By increasing acetylcholine synthesis, citicoline enhances cholinergic neurotransmission — the system most directly tied to sustained attention and executive function. A 2012 RCT in healthy women found significant improvements in focus and reduced omission errors on cognitive tests after 28 days at 250mg and 500mg.

Memory Support

Multiple trials in older adults with memory complaints show citicoline improves verbal memory and recall. The uridine component supports phosphatidylcholine synthesis in brain membranes — critical for the structural plasticity that underlies long-term memory formation.

Neuroprotection

Citicoline has been studied extensively as a neuroprotective agent following stroke and brain injury — it reduces ischemic damage, supports neuronal membrane repair, and has shown benefit in multiple clinical trials for post-stroke recovery in Europe and Japan.

Visual & Glaucoma Research

An emerging area of research shows citicoline may support retinal ganglion cell health and visual function, with small trials showing improvements in visual acuity and contrast sensitivity in patients with open-angle glaucoma.

Typical Dosage

Standard Daily Dose

250–500mg

Once or twice daily; some clinical trials use up to 1,000mg/day

What to Look For on the Label

Cognizin® branded citicoline

Cognizin is the most studied patented form; it has more human RCT backing than generic CDP-choline

Pro Tips

Can be taken with or without food — no strong evidence that meals affect absorption
Morning dosing is preferred — the mild stimulatory effect can interfere with sleep if taken late
Avoid stacking with Huperzine A without monitoring — both raise acetylcholine and the combination can cause headaches or brain fog in some people
Pairs well with Bacopa and Lion's Mane for a comprehensive cognitive stack

Research Snapshot

A 2012 randomized, double-blind, placebo-controlled trial by McGlade et al. in Food and Nutrition Sciences tested 250mg and 500mg of Cognizin citicoline daily in healthy adult women for 28 days. Both doses significantly improved attention and reduced omission errors on the Continuous Performance Test — with the 250mg dose showing particular improvements in motor speed. The study demonstrated cognitive benefits in healthy young adults, not just in those with deficits.

Source: McGlade E et al., Food and Nutrition Sciences (2012)

How Citicoline Compares

Ingredient	Best For	Key Difference
Citicoline	Focus, Memory, Brain Longevity	Dual mechanism (ACh + uridine); broad clinical evidence base
Alpha-GPC	Focus, Athletic Performance	Higher choline density; may support GH release; no uridine component
Choline Bitartrate	Budget choline source	Cheap and effective for meeting basic choline needs; less nootropic benefit
Phosphatidylserine	Memory, Cortisol, Aging	Membrane-targeted; complements citicoline's uridine mechanism

These are the most common comparisons our customers ask about in-store.

Popular Stacks with Citicoline

Daily Cognitive Stack

Citicoline + Bacopa Monnieri + Lion's Mane

Focus, memory consolidation & neurogenesis

Productivity & Focus

Citicoline + L-Theanine + Caffeine

Sustained attention without jitteriness

Brain Longevity

Citicoline + Phosphatidylserine + Omega-3

Membrane integrity + neurotransmitter support

Frequently Asked Questions

What is the difference between citicoline and Alpha-GPC?

Both are choline sources that support acetylcholine production, but citicoline also yields cytidine (which converts to uridine), supporting brain membrane synthesis. Alpha-GPC delivers a higher percentage of choline by weight and may have a slight edge for acute cognitive performance and growth hormone release. For long-term brain health, citicoline's dual mechanism is a strong argument in its favor.

How long does citicoline take to work?

Some users notice improved focus and mental clarity within a few days. Memory and cognitive benefits in clinical trials tend to be measured over 4–12 weeks. For age-related cognitive decline, studies typically run 3–6 months. Give it at least 4 weeks before evaluating effectiveness.

Can citicoline be taken with other nootropics?

Yes, citicoline stacks well with most nootropics. It's commonly combined with racetams, Lion's Mane, and Bacopa. Avoid combining with Huperzine A without monitoring — both raise acetylcholine, and excessive cholinergic activity can cause headaches, brain fog, or GI upset in sensitive individuals.

Sources & References

1. McGlade E et al. (2012). Improved attentional performance following citicoline administration in healthy adult women. Food and Nutrition Sciences, 3(6), 769–773.

2. Fioravanti M & Buckley AE. (2006). Citicoline (Cognizin) in the treatment of cognitive impairment. Clinical Interventions in Aging, 1(3), 247–251.

3. Secades JJ & Lorenzo JL. (2006). Citicoline: pharmacological and clinical review. Methods and Findings in Experimental and Clinical Pharmacology, 28(Suppl B), 1–56.

4. Grieb P. (2014). Neuroprotective properties of citicoline: facts, doubts and unresolved issues. CNS Drugs, 28(3), 185–193.

All references are peer-reviewed studies or position stands from reputable organizations.